ORTHOSON Ltd is a UK-based startup that is focused on developing bio-structural solutions for back pain. The company has gained attention for its innovative approach to addressing back pain and the causes of degeneration. Founded in 2015, ORTHOSON has made significant strides in the Health Care industry.
The company's flagship product is a micro-invasive bio-structural implant designed to restore the mechano-biology of the intervertebral disc, offering a promising treatment for back pain. This unique approach to back pain treatment has drawn the attention of investors, culminating in a successful £8.90M Series A investment led by Big Pi Ventures and Yonghua in May 2022.
By targeting the underlying causes of back pain and degeneration, ORTHOSON has positioned itself as a significant player in the health care startup landscape. The recent investment reflects the confidence of prominent investors in the startup's potential to make a meaningful impact in the field of bio-structural solutions and back pain treatment.